Healthcare ❯ Pharmaceuticals ❯ Drug Approval ❯ FDA

Eli Lilly

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

The move positions Lilly to challenge Novo Nordisk by pairing a more flexible pill with a rapid LillyDirect rollout and aggressive self-pay pricing.

FDA Clears Lilly’s Foundayo Pill, Escalating GLP-1 Weight-Loss Rivalry